Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells

Enzyme and Protein

Volumn 49, Issue 1-3, 1996, Pages 20-37

  Crawford, Howard C ^a   Matrisian, Lynn M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Collagenase; Ets; Fos; Jun; Matrilysin; Stromelysin

Indexed keywords

COLLAGENASE; DNA BINDING PROTEIN; MATRILYSIN; METALLOPROTEINASE; ONCOPROTEIN; STROMELYSIN; TRANSCRIPTION FACTOR AP 1;

BINDING SITE; CARCINOGENESIS; CARCINOMA; ENZYME REGULATION; EPITHELIUM CELL; FIBROBLAST; GENE STRUCTURE; ONCOGENE C FOS; ONCOGENE C JUN; PROMOTER REGION; PROTEIN DNA BINDING; REVIEW; STROMA CELL; TRANSCRIPTION REGULATION;

EID: 0029899015     PISSN: 10196773     EISSN: None     Source Type: Journal    
DOI: 10.1159/000468614     Document Type: Review

References (105)

1. Powell WC, Matrisian LW: Complex roles of matrix metalloproteinases in tumor progression: in Günther! U. Schlag PM, Birchmeier W (eds): Attempts to Understand Metastasis Formation. Metastasis-Related Molecules. In press.
2. Matrisian LM, Glaichenhaus N, Gesnel MC, Breathnach R: Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J 1985:4:1435-1440.
3. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grand GA, Seltzer JL, Kronberger A. Hauer EA, Goldberg G: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1 ) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988:263:6579-6587.
4. MacDougall JR. Matrisian LM: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1996:14:351-367.
5. Gutman A, Wasylyk B: Nuclear targets for transcriptional regulation by oncogenes. Trends Genet 1991:7: 49-54.
6. Wilson CL, Matrisian LM: Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996, in press.
7. Momiki S, Baba M, Caamano J, lizasa T, Nakajima M, Yamaguchi Y, Klein-Szanto A: In vivo and in vitro invasiveness of human lung carcinoma cell lines. Invasion Metastasis 1991;11:66-75.
8. Nethery A, O'Grady RL: Interstitial collagenase from rat mammary carcinoma cells: Interaction with substrates and inhibitors. Invasion Metastasis 1991:11:241-248.
9. Wright JH, McDonnell S, Portella G, Bowden GT, Balmain A, Matrisian LM: A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinog 1994;10:207-215.
10. Polette M, Clavel C, Muller D, Abecassis J, Binninger I, Birembaut P: Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization. Invasion Metastasis 1991; 11:76-83.
11. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T, Morimatsu M: Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma: A clinicopathologic study. Cancer 1992;70:2747-2753.
12. Foulds L: The experimental study of tumor progression: A review. Cancer Res 1954:14:327-339.
13. Portella G, Liddell J, Crombie R, Haddow S, Clarke M, Stoler A, Balmain A: Molecular mechanisms of invasion and metastasis during mouse skin tumour progression. Invasion Metastasis 1995;14:7-16.
14. BehrensJ: Cell contacts, differentiation, and invasiveness of epithelial cells. Invasion Metastasis 1995;14: 61-70.
15. Schorpp M, Mattel M, Herr I, Gack S, Schaper J, Angel P: Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem 1995:308:211-217.
16. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC, Gorstein F: Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 1993;168:253-260.
17. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, Gorstein F, Osteen KG: Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994;94:946-953.
18. Wilson CL, Heppner KJ, Rudolph LA, Matrisian LM: The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol. Biol. Cell 1995;6:851-869.
19. Saarialho-Kere UK, Crouch EC, Parks WC: The matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 1995;105:190-196.
20. Karelina TV, Goldberg GL Eisen AZ: Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia. J Invest Dermatol 1994;103:482-487.
21. Powell WC, Knox JD, Navre M, Grogan TM, Kittelson J, Nagle RB, Bowden GT: Expression of the metalloproteinase matrilysin in DU-145 cells increase their invasive potential in severe combined immunodeficiem mice. Cancer Res 1993:53:417-122.
22. Witty JP, McDonnell S, Newell K, Cannon P, Navre M, Tressler R, Matrisian LM: Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 1994:54:4805-1812.
23. Gack S, Vallon R, Schmidt J, Grigoriadis A, Tuckermann J, Schenkel J, Weiher H, Wagner EF, Angel P: Expression of interstitial collagenese during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophie chondrocytes. Cell Growth Differ 1995;6:759-767.
24. Talhouk RS, Bissell MJ, Werb Z: Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 1992;! 18:1271-1282.
25. Witty JP, Wright J, Matrisian LM: Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995;6:1287-1303.
26. Gack S, Vallon R, Schaper J, Rüther U, Angel P: Phenotypic alterations in Fos-transgenic mice correlate with changes in Fos/Jun-depenent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP; and Fos oncoprotein. J Biol Chem 1994;269:10363-10369.
27. Stricklin GP, Li L, Jancic V, Wenczak BA, Nanney LB: Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol 1993;143:1657-1666.
28. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG: Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 1994;94:79-88.
29. Wright JH, Balmain A, Matrisian LM: Metalloproteinase expression during the progression of chemicallyinduced mouse skin tumors (abstract). Clin Exp Metastasis 1994;12:62.
30. Stoler AB, Stenback F, Balmain A: The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J Cell Biol 1993:122:1103-1117.
31. Crawford HC, Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 1995;14:234-245.
32. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K: High expression of 92-kD type IV collagenase (gelatinase) in the osteoclast lineage during mouse development. Ann NY Acad Sei 1994;732:472-475.
33. Witty JP, Foster SA, Stricklin GP, Matrisian LM, Stern PH: Parathyroid hormone-induced résorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Min Res 1996:11:72-78.
34. Basset P, BellocqJP, WolfC, Stoll I, Hutin P, LimacherJM, PodhajcerOL, ChenardMP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
35. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H, Dumont P, Eber M, Abecassis J: Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 1991:48:550-556.
36. Huhtala P, Chow LT. Tryggvason K: Structure of the human type IV collagenase gene. J Biol Chem 1990:265: 11077-11082.
37. Anglard P, Melot T, Guerin E, Thomas G, Basset P: Structure and promoter characterization of the human stromeIysin-3 gene. J Biol Chem 1995:270:20337-20344.
38. Fini ME, Strissel KJ. Girard MT, West Mays J, Rinehart WB: Interleukin-la mediates collagenase synthesis stimulated by phorbol 12-myristate 13-acetate. J Biol Chem 1994;269:11291-11298.
39. Sato H, Seiki M: Regulatory mechanism of 92 kD type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993:8:395-405.
40. Gaire M, Magbanua Z, McDonnell S, McNeil L. Lovett DH, Matrisian LM: Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 1994:269:2032-2040.
41. Sciavolino PJ, Lee TH, Vilcek J: Interferon-β induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1. J Biol Chem 1994:269:21627-21634.
42. Tremble P Damsky CH. Werb Z: Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals. J Cell Biol 1995:129:1707-1720.
43. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex cell proliferation and transformation (review). Biochim Biophys Acta 1991:1072:129-157.
44. Kerr LD, Holt JT, Matrisian LM: Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 1988:242:1424-1427.
45. McDonnell SE. Kerr LD, Matrisian LM: Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol 1990:10:4284-4293.
46. Schonthal A, Herrlich P, Rahmsdorf H, Ponta H: Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 1988:35:325-334.
47. Domann FE, Levy JP, Birrer MJ, Bowden GT: Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Diff 1994:5:9-16.
48. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH: Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sei USA 1994:91:609-613.
49. Martin ME, Piette J, Yaniv M. Tang WJ, Folk WR: Activation of the polyomavirus enhancer by a murine activator protein l homolog and two contiguous proteins. Proc Nat Acad Sei USA 1988:85:5839-5843.
50. Wasylyk C, Flores P, Gutman A, Wasylyk B: PEA3 is a nuclear target for transcription activation by nonnuclear oncogenes. EMBO J 1989;8:3371-3378,
51. Gutmann A. Wasylyk B: The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 1990;9:2241-2246.
52. Wasylyk C, Gutman A, Nicholson R, Wasylyk B: The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 1991:10:1127-1134.
53. Wasylyk B, Wasylyk C. Flores P. Begue A, Leprince D, Stehelin D: The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 1990:346:191-193.
54. Bergelson S, Daniel V: Cooperative interaction between Ets and AP-1 transcription factors regulates induction of glutathione S-transferase Ya gene expression. Biochem Biophys Res Commun 1994:200:290-297.
55. Edwards DR, Rocheleau H. Sharma RR. Wills AJ, Cowie A, Hassell JA, Heath JK: Involvement of API and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 transcription. Biochim Biophys Acta 1995;! 171:41-55.
56. Nerlov C. DeCesare D. Pergola F. Caracciolo A, Blasi F, Johnsen M, Verde P: A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction or urokinase enhancer aclivity in HepG2 hepatoma cells. EMBO J 1992:11:4573-f582.
57. Chamberlain SH, Hemmer RM. Brinckerhoff CE: Novel phorbol ester response region in the collagenase promoter binds Fos and Jun. J Cell Biochem 1993:52:337-351.
58. White LA, Brinckerhoff CE: Two AP-1 elements in the collagenase (MMP-1) promoter have differential effects on transcription and bind JunD, c-Fos, and Fra-2. Matrix Biol 1995:14:715-725.
59. Nerlov C, Rorth P, Blasi F, Johnsen M: Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 1991:6:1583-1592.
60. Belaaouaj A, Shipley JM, Kobayashi DK, Zimonjic DB, Popescu N, Silverman G A, Shapiro SD: Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem 1995:270:14568-14575.
61. Risse G, Jooss K, Neuberg M, Bruller HJ. Muller R: Asymmetrical recognition of the palindromic API-binding site (TRE) by Fos protein complexes. EMBO J 1989:8:3825-3832.
62. Mauviel A. Kahari VM, Kurkinen M, Evans CH. Uitto J: Leukoregulin, a T-cell-derived cytokine, upregulates stromelysin-1 gene expression in human dermal fibroblasts: Evidence for the role of AP-1 in transcriptional activation. J Cell Biochem 1992:50:53-61.
63. Brinckerhoff CE, Sirum-Connolly KL, Karmilowicz MJ, Auble DT: Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts. Matrix 1992:l(suppl):165-175.
64. Fini ME, Bartlett JD, Matsubara M, Rinehart WB, Mody MK. Girard MT, Rainville M: The rabbit gene for 92-kD matrix metalloproteinase. Role of API and AP2 in cell type-specific transcription. J Biol Chem 1994:269:28620-28628.
65. Dony C, Gruss P: Proto-oncogene c-fos expression in growth regions of fetal bone and mesodermal web tissue. Nature 1987:328:711-714.
66. Caubet JF, Bernaudin JF: Expression of the c-fos proto-oncogene in bone, cartilage and tooth-forming tissues during mouse development. Biol Cell 1988;64:10H04.
67. De Togni P, Niman H, Raymond V, Sawchenko P, Verma IM: Detection of fos protein during osteogenesis by monoclonal antibodies. Mol Cell Biol 1988;8:2251-2256.
68. McCabe LR, Kockx M, Lian J, Stein J, Stein G: Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Exp Cell Res 1995;218:255-262.
69. Beuerman RW, Thompson HW: Molecular and cellular responses of the corneal epithelium to wound healing. Acta Ophthalmol 1992(suppl):7-12.
70. Martin P, Nobes CD: An early molecular component of the wound healing response in rat embryos - induction of c-fos protein in cells at the epidermal wound margin. Mech Dev 1992;38:209-215.
71. Nephew KP, Peters GA, Khan SA: Cellular localization of estradiol-induced c-fos messenger ribonucleic acid in the rat uterus: c-fos expression and uterine cell proliferation do not correlate strictly. Endocrinology 1995:136:3007-3015.
72. Hu E, Mueller E, Oliviero S, Papaioannou VE, Johnson R, Spiegelman BM: Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimuated by growth factors or oncogenes. EMBO J 1994;13:3094-3103.
73. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM: c-fos is required for malignant progression of skin tumors. Cell 1995;82:721-732.
74. Marshall-Heyman H, Engel G, Ljungdahl S, Shoshan MC, Svensson C, Wasylyk B, Under S: Tumorigenic and metastatic properties of two ras-oncogene transfected rat fibrosarcoma cell lines defective in c-jun. Oncogene 1994:9:3655-3663.
75. Bigsby RM, Li A: Differentially regulated immediate early genes in the rat uterus. Endocrinology 1994;134: 1820-1826.
76. Nephew KP, Tang M, Khan SA: Estrogen differentially affects c-jun expression in uterine tissue compartments. Endocrinology 1994;134:1827-1834.
77. Chiu R, Angel P, Karin M: Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 1989;59:979-986.
78. Schutte J, Viallet J, Nau M, Segal S, Fedorko J, Minna J: Jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 1989;59:987-997.
79. Hirai SI, Ryseck RP, Mechta F, Bravo R, Yaniv M: Characterization of junD: A new member of the jun protooncogene family. EMBO J 1989;8:1433-1439.
80. Yang-Yen HE, Chiu R, Karin M: Elevation of API activity during F9 cell differentiation is due to increased c-jun transcription. New Biol 1990;2:351-361.
81. Mauviel A: Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 1993;53:288-295.
82. Mauviel A, Chung KY, Agarwal A, Tamai K, Uitto J: Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-β in fibroblasts and keratinocytes. J Biol Chem 1996, in Press.
83. Wilkinson DO, Bhatt S, Ryseck RP, Bravo R: Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development 1989;!06:465-471.
84. Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R, Balmain A: Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice. Oncogene 1991 ;6:2363-2369.
85. Domann FE Jr, Levy JP, Finch JS, Bowden GT: Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol Carcinog 1994:9:61-66.
86. Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P: Cross-coupling of the NFicB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 1993:12:3879-3891.
87. Goldberg Y, TreierM, GhysdaelJ, Bohmann D: Repression of AP-1-stimulated transcription by c-Ets-1. J Biol Chem 1994;269:16566-16573.
88. Tymms MJ, Kola I: Regulation of gene expression by transcriptions factors Ets-1 and Ets-2. Mol Reprod Dev 1994;39:208-214.
89. Queva C, Leprince D, Stehelin D, Vandenbunder B: p54c-ets-l and p68-c-ets-l, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo. Oncogene 1993;8:2511-2520.
90. Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS, Seth A: The Etsl transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sei USA 1993;90:7588-7592.
91. Wernert N, Raes MB, Lassalle P, Dehouck MP, Gosselin B, Vandenbunder B, Stehelin D: c-etsl proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 1992;140:119-127.
92. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C, Dupressoir T, Seitz G, Vandenbunder B, Stehelin D: Stromal expression of c-Etsl transcription factor correlates with tumor invasion. Cancer Res 1984;54:5683-5688.
93. Vandenbunder B, Oueva C, Desbiens X, Wernert N, Stehelin D: Expression of the transcription factor c-Etsl correlates with the occurrence of invasive processes during normal and pathological development. Invasion Metastasis 1995;14:198-209.
94. Borchers AH, Powell MB, Fusenig NE, Bowden GT: Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp Cell Res 1994;213:143-147.
95. ChenJH: The proto-oncogenee c-ets is preferentially expressed in lymphoid cells. Mol Cell Biol 1983:5: 2993-3000.
96. Ghysdael J, Gegonne A, Pognonec P, Dernis D, Leprince D, Stehelin D: Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein. Proc Natl Acad Sei USA 1986:83:1714-1718.
97. Buttice G, Kurkinen M: A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. ! Biol Chem 1993:268:7196-7204.
98. Kerr LD, Miller DB, Matrisian LM: TGF-beta-1 inhibition of transin-stromelysin gene expression is mediated through a fos binding sequence. Cell 1990:61:267-278.
99. Nakanishi H. Taylor RM. Chrest FJ, Masui T, Utsumi K, Tatematsu M, Passaniti A: Progression of hormonedependent adenocarcinoma cells to hormone-independent spindle carcinoma cells in vitro in a clonal sponta neous rat mammary tumor cell line. Cancer Res 1995:55:399-407.
100. MacDougall JR, Bani MR, Un Y, Rak J, Kerbel RS: The 92-kD gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 1995: 55:4174-181.
101. Sirum K, Brinckerhoff C: Cloning of the genes for human stromelysin and stromelysin-2: Differential expression in rheumatoid synovial fibroblasts. Biochemistry 1989:28:8691-8698.
102. Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ, Herrlich P: 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region. Mol Cell Biol 1987;7:2256-2266.
103. Angel P, Imagawa M, Chiu R, Stein B, Imbra R, Rahmsdorf H. Jonat C, Herrlich P. Karin M: Phorbol esterinducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987;49:729-739.
104. Huhtala P, Tuuttila A, Chow LT, Lohi J. Keski-Oja J, Tryggvason K: Complete structure of the human gene for 92-kD type IV collagenase. Divergent regulation of expression for the 92 and 72-kD enzyme genes in HT1080 cells. J Biol Chem 1991;266:16485-16490.
105. Balmain A, Ramsden M, Bowden G, Smith J: Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 1984:307:658-660.